Viewing Study NCT01089218



Ignite Creation Date: 2024-05-05 @ 10:21 PM
Last Modification Date: 2024-10-26 @ 10:17 AM
Study NCT ID: NCT01089218
Status: COMPLETED
Last Update Posted: 2011-07-21
First Post: 2010-03-14

Brief Title: The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines
Sponsor: Seoul National University Hospital
Organization: Seoul National University Hospital

Study Overview

Official Title: The Impact of Antibiotic Prophylaxis on Incidence of Post-bronchoscopy Fever and Change of Serum Cytokines
Status: COMPLETED
Status Verified Date: 2011-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Fever can develop after fiberoptic bronchoscopy FB in about 25 - 16 of adult patients We evaluated the impact of oral amoxicillinclavulanate AC on incidence of postbronchoscopic fever and pneumonia
Detailed Description: For the population being undergone with bronchoscopy the clinical signs and procedural measures for complication of bronchoscopy and cytokines will be checked

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None